You are here

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Pharmacology and therapeutics
Research
Health Canada's use of its priority review process for new drugs: a cohort study

Authors

  • Joel Lexchin School of Health Policy and Management, York University, Toronto, Ontario, Canada University Health Network, Toronto, Ontario, Canada Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Joel Lexchin; jlexchin{at}yorku.ca
View Full Text

Citation

Lexchin J
Health Canada's use of its priority review process for new drugs: a cohort study
BMJ Open 2015;5:e006816. doi: 10.1136/bmjopen-2014-006816

Publication history

  • Received October 2, 2014
  • Revised March 13, 2015
  • Accepted March 26, 2015
  • First published May 11, 2015.
Online issue publication 
April 22, 2019
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/